Oragenics Capital Expenditures (CapEx) Growth & History (OGEN)

Oragenics's capital expenditures (capex) was $1.0M for fiscal 2023.

View full Oragenics company overview

Oragenics annual capital expenditures (capex) history

Oragenics annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20232023-12-31$1.0M$872,481+684.20%
20222022-12-31$127,519$83,643+190.63%
20212021-12-31$43,876
20192019-12-31$25,214−$99,513−79.78%
20182018-12-31$124,727
20162016-12-31$27,179−$75,332−73.49%
20152015-12-31$102,511−$8,162−7.37%
20142014-12-31$110,673$91,864+488.40%
20132013-12-31$18,809$7,714+69.53%
20122012-12-31$11,095
20102010-12-31$88,084

Oragenics capital expenditures (capex) trends

Over the last five fiscal years, Oragenics's capital expenditures (capex) increased from $124,727 to $1.0M, a change of $875,273. The latest reported quarter, Q4 2022, shows $3,438.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Oragenics source filings ↗

Community posts

It’s quiet here.

No posts about OGEN yet. Start the conversation.

Write the first post